Skip to main content
. 2018 Aug 1;10(2):521–530. doi: 10.1111/jdi.12891

Table 1.

Clinical characteristics of 557 participants before the earthquakes

Type 1 diabetes Type 2 diabetes Others
n 55 449 53
Age (years) 51.2 ± 16.4 63.4 ± 11.9 59.3 ± 12.7
Male/female 20/35 239/210 20/33
BMI 22.2 ± 3.7 25.4 ± 4.8 23.9 ± 4.8
Diabetes history (years) 20.0 ± 9.8 14.6 ± 9.5 9.1 ± 7.2**
Blood glucose (mg/dL) 177.4 ± 72.3 150.9 ± 47.3 135.4 ± 49.9
HbA1c (%) 8.23 ± 1.54* 7.26 ± 1.07 7.08 ± 1.28
GA (%) 26.6 ± 7.3 18.6 ± 3.8 19.4 ± 6.7
SBP (mmHg) 121.0 ± 16.5 128.6 ± 17.1 124.9 ± 16.0
DBP (mmHg) 67.5 ± 13.2 72.6 ± 11.8 72.8 ± 11.8
HR (b.p.m) 76.8 ± 12.0 77.7 ± 12.2 79.2 ± 13.4
Retinopathy 36.60% 29.40% 20.50%
Nephropathy 28.20% 35.6%§ 22.50%
Neuropathy 34.30% 34.20% 20.30%
OHA 15.50% 81.6% 55.40%
Insulin 98.6% 33.80% 59.5%††
GLP‐1RA 0% 10.0% 5.40%

Data are presented as means or ratio (%). The Fisher's exact test with Bonferroni correction were carried out. *P = 0.002 type 1 diabetes vs type 2 diabetes. P < 0.001 type 1 diabetes vs type 2 diabetes or specific types of diabetes due to other causes (Others). P < 0.001 type 2 diabetes vs type 1 diabetes or Others. § P = 0.037 type 2 diabetes vs Others. **P < 0.001 Others vs type 1 diabetes or type 2 diabetes. †† < 0.001 Others vs type 2 diabetes. DBP, diastolic blood pressure; GA, glycated albumin; GLP‐1RA, glucagon like peptide‐1 receptor agonist; HbA1c, glycated hemoglobin; HR, heart rate; OHA, oral hypoglycemic agents; SBP, systolic blood pressure.